The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions

Levothyroxine timing: a real interaction with a simple fix

AB
a.batistaTL2 Moderator29 Sep 2024#1

Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did.

Reporting something rather than asking about it, in case the pattern is useful to anyone else.

Over 22 weeks I logged this consistently: date, dose, time of day, and a simple severity score from 0 to 4 for each symptom. That is 178 data points, all self-reported, all unblinded, and collected by someone who knew what he expected to find. Treat it accordingly.

The reason I am posting is that my experience does not match the shape people usually describe here, and I would like to know whether that is unusual or whether the usual description is just the loudest version.

16 likes 22mo
IT
impurity_tableTL3Analytical chemist9 Oct 2024#2

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

2 likes 22mo
MS
m.steinerTL2 Moderator16 Oct 2024#3

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

0 likes 21mo
BV
bias_varianceTL4Biostatistician22 Oct 2024#4

Picking up post #3: that is the part I would want checked first.

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

20 likes 21mo
NL
n.laurentTL2 Moderator28 Oct 2024#5

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

13 likes 21mo
TV
t.vasquezTL4 Moderator3 Nov 2024#6
m.steiner, post #3: Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management. Go to post

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

4 likes in reply to #3 21mo
IN
i.norgaardTL2 Moderator9 Nov 2024 · edited#7

I read post #5 twice before replying, because I had assumed the opposite.

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

0 likes 21mo
CR
compounding_ruthTL4Pharmacist14 Nov 2024#8

This follows post #5 rather than contradicting it.

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

27 likes 20mo
HF
h.friskTL2 Moderator19 Nov 2024 · edited#9

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

2 likes 20mo
JR
j.rasmussenTL2Regular24 Nov 2024#10
n.laurent, post #5: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

post #9 answers the question as asked. The question underneath it is different.

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

0 likes in reply to #5 20mo
TK
t.kulkarniTL3Regular29 Nov 2024#11

post #10 is right about the mechanism and I think understates the practical bit.

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

0 likes 20mo
PN
p.novakTL2 Moderator3 Dec 2024#12
n.laurent, post #5: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Worth separating two things that post #8 runs together.

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

0 likes in reply to #5 20mo
HA
h.almeidaTL2Member8 Dec 2024#13
compounding_ruth, post #8: This follows post #5 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion. Go to post

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

7 likes in reply to #8 20mo
TM
t.marchettiTL2 Moderator13 Dec 2024#14

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

18 likes 19mo
IS
isotonic_sheetTL3Regular17 Dec 2024#15

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

0 likes 19mo
NK
ni.kravchenkoTL2 Moderator21 Dec 2024#16
n.laurent, post #5: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

On post #12 — agreed on the reasoning, with one qualification.

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

1 like in reply to #5 19mo
RJ
r.jhannsdttirTL3Regular26 Dec 2024 · edited#17

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

12 likes 19mo
AV
a.vermeulenTL2 Moderator30 Dec 2024#18

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

25 likes 19mo
MM
maintenance_modeTL3Regular3 Jan 2025#19

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

0 likes 19mo
FD
f.danquahTL2 Moderator7 Jan 2025#20

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

4 likes 19mo
MM
m.marchettiTL2 Moderator11 Jan 2025#21

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

18 likes 18mo
I
IHollingworthTL2Member16 Jan 2025#22

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

7 likes 18mo
CN
c.nybergTL2 Moderator20 Jan 2025#23
m.steiner, post #3: Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management. Go to post

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

1 like in reply to #3 18mo
LS
l.sarkissianTL2Member24 Jan 2025#24
m.marchetti, post #21: Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management. Go to post

Picking up post #21: that is the part I would want checked first.

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

0 likes in reply to #21 18mo
RS
r.sobczakTL2 Moderator28 Jan 2025#25

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

25 likes 18mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Antibiotics and a course of something with delayed emptying
Antibiotics and a course of something with delayed emptying — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is useful…
TTSTMGMMIB+99 108 1.4k 12mo
Delayed gastric emptying and oral medication absorption: which drugs matter
On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter Working notes rather than a conclusion. Reporting something rather than asking about it, in case the…
RGSGIIIAGT+110 116 43k 14mo
Alcohol: what is documented and what is folklore
Posting this under the heading it deserves: Alcohol: what is documented and what is folklore Everything below is what sits behind that. A question about technique rather than about dose. I have been doing the…
TVRPPNCJM+120 134 11k 2d
Follow-up: Reading an interaction checker output critically
Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I am asking rather…
MNWVSGSR+62 66 13k 2d
Follow-up: Oral contraceptives and delayed emptying: what the data shows
Oral contraceptives and delayed emptying: what the data shows — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is…
KMPEHBMSRL+31 35 13k 18mo

Related topics — sharing the tags needs a source, metformin, hypoglycaemia

TopicParticipantsRepliesViewsActivity
Muscle cramps: the ordinary causes before the exotic ones
Muscle cramps: the ordinary causes before the exotic ones Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
JHBSRISGBT+80 90 27k 6mo
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
NKRGBNMSDT+47 51 37k 3mo
Why catalogue breadth is not evidence of anything
Why catalogue breadth is not evidence of anything I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a claim I…
CBKAV 2 38k 2d
Signs of dehydration worth acting on
Signs of dehydration worth acting on — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this class mostly…
TNMNBPTBI+34 38 5.9k 21mo
Sequence verification for an obscure compound: how it is done
Sequence verification for an obscure compound: how it is done Writing it up because I had to work it out twice and would rather nobody else did. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with SURMOUNT-1 ( N…
BNGVIAJVGE+104 114 10k 12mo